Literature DB >> 18560795

Hypothyroidism and cerebral vein thrombosis--a possible association.

Ana Rita Peralta1, Patrícia Canhão.   

Abstract

BACKGROUND: There are many systemic illnesses that constitute risk factors for cerebral vein thrombosis (CVT). Hypothyroidism was never associated with CVT, despite growing evidence supporting a possible etiopathogenic link. We report two patients with CVT in whom hypothyroidism was concomitantly diagnosed. CLINICAL CASES: Cases were women 21 and 52 years old. They both presented with intracranial hypertension syndrome and symptomatic focal epilepsy. CVT was diagnosed with MRI and MR venography. Hypothyroidism was diagnosed in the acute phase of CVT. Both had an autoimmune thyroiditis. None of the patients had diffuse goitre. Other risk factors for CVT were oral contraceptives and elevated homocysteine in one and hormonal replacement therapy in the other. Both were treated with anticoagulation, anti-epileptic drugs and thyroid replacement therapy, with good clinical outcome.
CONCLUSIONS: The association found between untreated hypothyroidism and CVT in these patients may result from chance. However, several haemostatic and fibrinolytic parameters have been demonstrated to be disturbed in hypothyroidism suggesting a possible role of this disease in CVT pathogenesis. In addition, indirect evidence also supports possible endothelial dysfunction and venous stasis in hypothyroidism, further emphasizing the physiopathological link between the two conditions. More research is needed to determine a possible causal role of hypothyroidism on CVT. We suggest that thyroid function should be included in the usual workup of CVT patients.

Entities:  

Mesh:

Year:  2008        PMID: 18560795     DOI: 10.1007/s00415-008-0746-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.

Authors:  M J Diekman; N M van der Put; H J Blom; J G Tijssen; W M Wiersinga
Journal:  Clin Endocrinol (Oxf)       Date:  2001-02       Impact factor: 3.478

2.  Left ventricular performance in subclinical hypothyroidism.

Authors:  J C Forfar; C G Wathen; W T Todd; G M Bell; W J Hannan; A L Muir; A D Toft
Journal:  Q J Med       Date:  1985-12

3.  Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey.

Authors:  M S Morris; A G Bostom; P F Jacques; J Selhub; I H Rosenberg
Journal:  Atherosclerosis       Date:  2001-03       Impact factor: 5.162

4.  Os odontoideum associated with hypertrophic ossiculum terminale. Case report.

Authors:  H Sakaida; S Waga; T Kojima; Y Kubo; S Niwa; T Matsubara
Journal:  J Neurosurg       Date:  2001-01       Impact factor: 5.115

5.  Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism.

Authors:  William J Hueston; Dana E King; Mark E Geesey
Journal:  Clin Endocrinol (Oxf)       Date:  2005-11       Impact factor: 3.478

6.  The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.

Authors:  Omer Ozcan; Erdinc Cakir; Halil Yaman; Emin Ozgur Akgul; Kivilcim Erturk; Zeynel Beyhan; Cumhur Bilgi; Mehmet Kemal Erbil
Journal:  Clin Endocrinol (Oxf)       Date:  2005-08       Impact factor: 3.478

7.  Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism.

Authors:  Ayse S Cikim; Huseyin Oflaz; Nese Ozbey; Kerim Cikim; Sabahattin Umman; Mehmet Meric; Ergin Sencer; Senay Molvalilar
Journal:  Thyroid       Date:  2004-08       Impact factor: 6.568

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.

Authors:  Cihangir Erem
Journal:  Clin Endocrinol (Oxf)       Date:  2006-03       Impact factor: 3.478

10.  [Cerebral venous thrombosis associated to subacute De Quervain's thyroiditis in a carrier for the G20210A mutation of the prothrombin gene].

Authors:  A B Madroñero-Vuelta; J Sanahuja-Montesinos; M Bergua-Llop; C Araguás-Arasanz
Journal:  Rev Neurol       Date:  2004 Sep 16-30       Impact factor: 0.870

View more
  5 in total

1.  Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Gian Luca Salvagno; Gian Cesare Guidi; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2008-09-12       Impact factor: 2.300

2.  Hypothyroidism, Sex, and Age Predict Future Thromboembolic Events Among Younger People.

Authors:  Jay A Martinez; Fares Qeadan; Mark R Burge
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

3.  Elderly patient with dural sinus thrombosis leading to abnormal medullary veins and cerebral venous infarctions.

Authors:  Alessandro D'Amore; Giorgio Conte; Adriano Viglianesi; Emma Gabriella Muscoso; Rita Chiaramonte; Ignazio Chiaramonte
Journal:  Radiol Case Rep       Date:  2015-12-07

Review 4.  Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-03-09

5.  Thyroid dysfunction in cerebral venous thrombosis: a retrospective cohort study.

Authors:  Simon Fandler-Höfler; Stefan Pilz; Marion Ertler; Melanie Haidegger; Markus Kneihsl; Gerit Wünsch; Thomas Gary; Christian Enzinger; Thomas Gattringer
Journal:  J Neurol       Date:  2021-09-01       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.